{"id":"W2292975070","doi":"10.1111/bjh.14007","title":"Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Clinical endpoint; Randomization; Lymphoma; Randomized controlled trial; Oncology; Asymptomatic; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006156128,0.0004708032,0.002352704,0.0002469323,0.000196059,0.00007390034,0.0002947072,0.0004267196,0.0003925718],"category_scores_gemma":[0.0003935643,0.0003075487,0.000637696,0.000170877,0.0002383461,0.0002338863,0.0001063524,0.0002101381,0.00009533826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001183155,"about_ca_system_score_gemma":0.00211561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009272798,"about_ca_topic_score_gemma":0.0001292074,"domain_scores_codex":[0.9962071,0.0003492709,0.001607092,0.0005926762,0.0004990352,0.0007447838],"domain_scores_gemma":[0.9968409,0.0004934411,0.001116853,0.0003378486,0.0007282406,0.0004827434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2839782,0.04998688,0.002472485,0.001133406,0.003941828,0.3542099,0.001182105,0.00001095139,0.006427307,0.0002761199,0.01699578,0.279385],"study_design_scores_gemma":[0.7016237,0.04615651,0.00122603,0.003482685,0.000996463,0.1896957,0.0004854962,0.0001162292,0.03878226,0.000177683,0.01674488,0.0005122722],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9401565,0.0006444985,0.001590795,0.002057998,0.0006502581,0.05436438,0.00006567498,0.00003441323,0.0004355101],"genre_scores_gemma":[0.947897,0.0002630956,0.00608992,0.0004159262,0.0008876632,0.04347297,0.00001709408,0.00008409535,0.0008722129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4176456,"threshold_uncertainty_score":0.9999377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02048215489209315,"score_gpt":0.3183431877896765,"score_spread":0.2978610328975834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}